Altimmune (ALT) Stock Chart & Stock Price History $8.05 +0.58 (+7.76%) (As of 11/20/2024 ET) Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Altimmune Stock Price Performance 5 Day Performance+5.78%1 Month Performance+16.67%3 Month Performance+17.18%6 Month Performance+4.55%Year-To-Date Performance-28.44%1 Year Performance+216.93% Receive ALT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Altimmune and its competitors with MarketBeat's FREE daily newsletter. Email Address JD Vance Predicts: Wall Street vs. Trump & Your Money (Ad)Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.Get your free guide NOW before it's too late. ALT Stock Chart for Thursday, November, 21, 2024 ALT Chart by TradingView Altimmune Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization11/20/2024$7.47$8.05+7.76%$8.42$7.524.75 million shs$572.52 million11/19/2024$7.15$7.47+4.48%$7.48$6.982.72 million shs$531.27 million11/18/2024$7.61$7.15-6.04%$7.55$6.954.48 million shs$508.54 million11/15/2024$8.46$7.61-9.99%$8.54$7.465.39 million shs$541.22 million11/14/2024$9.52$8.46-11.19%$9.70$8.335.13 million shs$600.91 million11/13/2024$9.49$9.52+0.32%$11.16$9.4610.07 million shs$676.59 million Get the Latest News and Ratings for ALT and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Altimmune and its competitors with MarketBeat's FREE daily newsletter. 11/12/2024$7.35$9.49+29.12%$10.02$7.4618.53 million shs$674.45 million11/11/2024$7.68$7.35-4.30%$7.96$6.934.78 million shs$522.36 million11/08/2024$7.46$7.68+2.95%$7.68$7.371.93 million shs$545.82 million11/07/2024$7.31$7.46+2.05%$8.05$7.404.23 million shs$530.18 million11/06/2024$7.03$7.31+3.98%$7.41$7.082.66 million shs$519.53 million11/05/2024$6.79$7.03+3.53%$7.03$6.641.68 million shs$499.62 million11/04/2024$6.74$6.79+0.74%$6.84$6.452.06 million shs$482.57 million11/01/2024$6.74$6.74$7.20$6.622.12 million shs$479.01 million10/31/2024$6.76$6.74-0.30%$6.86$6.581.66 million shs$479.02 million10/30/2024$7.36$6.76-8.15%$7.30$6.742.30 million shs$480.44 million10/29/2024$7.01$7.36+4.99%$7.58$6.853.57 million shs$523.08 million10/28/2024$6.69$7.01+4.78%$7.18$6.771.86 million shs$498.20 million10/25/2024$6.77$6.69-1.11%$7.05$6.691.29 million shs$474.33 million10/24/2024$6.72$6.77+0.67%$6.97$6.651.48 million shs$479.65 million10/23/2024$6.80$6.72-1.18%$6.85$6.521.46 million shs$476.46 million10/22/2024$6.90$6.80-1.45%$6.96$6.67915,510 shs$482.13 million10/21/2024$6.88$6.90+0.29%$6.97$6.631.21 million shs$489.22 million Related Companies Arbutus Biopharma Stock Price Chart Kamada Stock Price Chart Fulcrum Therapeutics Stock Price Chart BeyondSpring Stock Price Chart Unity Biotechnology Stock Price Chart MEI Pharma Stock Price Chart Amphastar Pharmaceuticals Stock Price Chart Apogee Therapeutics Stock Price Chart Mirum Pharmaceuticals Stock Price Chart Centessa Pharmaceuticals Stock Price Chart Receive ALT Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Altimmune and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ALT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Altimmune, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Altimmune With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
